New York, NYNCT04751435Now EnrollingIRB Ready

Educational Materials for Genetic Testing Clinical Trial in New York, NY

Access cutting-edge educational materials for genetic testing treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by Memorial Sloan Kettering Cancer Center

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions…

Expert Care in New York

Access educational materials for genetic testing specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related educational materials for genetic testing treatment provided free

Apply for This New York Location

Check if you qualify for this educational materials for genetic testing clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This Educational Materials for Genetic Testing Study in New York

Genetic testing is a type of test that detects changes to the genes-the DNA instructions that are passed on from the mother and father. The results of a genetic test can confirm whether the participant has a genetic disorder, which is a disease caused in whole or in part by changes to the genes. Genetic testing can also help determine a person's chance of getting or passing on a genetic disorder. Genetic tests use a sample of blood, hair, skin, or other tissue, and they can look at one gene or multiple genes at the same time. Genetic testing may change the options for treating people with certain types of cancer. For example, some medications are more helpful for the treatment of cancer in people with certain gene changes (mutations). The researchers are doing this study to develop new educational materials about genetic testing for people who speak different languages and have diverse cultural and educational backgrounds. During the study, the staff will interview participants with diverse cultural and educational backgrounds and ask them to review a sample of the educational materials that have been developed so far. Participants will give their opinions on these materials, and the researchers will use participants' feedback to improve the materials.

Sponsor: Memorial Sloan Kettering Cancer Center

Who Can Participate

Inclusion Criteria

Age ≥ 18 years as per self-report
Current or previous diagnosis of breast, ovarian, pancreatic, or prostate cancer as per self-report
Self-identification as Black, Latino, and/or neither Black nor Latino (i.e.,non-Latino, Non black)
Fluency in English, Haitian Creole, or Spanish as per self-report (for Spanish, we will attempt to recruit a cohort representing a variety of regions where Spanish is spoken, as informed by current data from participating sites, to achieve neutrality in the language) Fluency is defined as an answer of "well" or "very well" on the screening questions for spoken and reading ability. Phase 2:
Age ≥ 18 years as per the medical record
Current or previous diagnosis of breast, colorectal, ovarian, pancreatic, or prostate cancer meeting at least one of the applicable criteria for the cancer type as per the medical record and/or clinician referral:
Breast cancer criteria:
any diagnosis age 65 or younger;
diagnosis of triple negative breast cancer at any age;
multiple primary breast cancers at any age;
under consideration for PARP therapy;
any family history (1st, 2nd, or 3rd degree relatives) of ovarian or pancreas cancer, or 1 relative with breast cancer who meets the above criteria, or 2 relatives with breast cancer at any age; or clinician discretion)
Colorectal cancer criteria:
any diagnosis age 50 and below;
mismatch repair deficient colorectal cancer;
colorectal cancer at any age with an additional Lynch syndromerelated primary cancer at any age;
colorectal cancer at any age with a 1st or 2nd degree relative with colorectal cancer at/before age 50;
colorectal cancer at any age with 2 or more 1st or 2nd degree relatives with a Lynch syndrome-related cancer at any age
Ovarian cancer criteria: ° invasive ovarian cancer
Pancreatic cancer criteria: ° pancreatic adenocarcinoma
Prostate cancer criteria:
castrate-resistant, metastatic prostate cancer;
high-risk prostate cancer (pending pathology definition)
Fluency in English, Haitian Creole, or Spanish as per self-report. Fluency is defined as an answer of "well" or "very well" on the screening questions for spoken ability
No prior cancer genetic counseling or germline testing for cancer risk as per self-report clinician's note, and/or no clinical documentation

Exclusion Criteria

Individuals of impaired decision-making capacity as per a clinician's or consenting professional's judgment.
Subjects who indicate level of fluency as "not at all" or "not well". Phase 2:
Individuals of impaired decision-making capacity as per a clinician's or consenting professional's judgment.
Subjects who indicate level of fluency as "not at all" or "not well".

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT04751435) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Educational Materials for Genetic Testing Treatment Options in New York, NY

If you're searching for educational materials for genetic testing treatment options in New York, NY, this clinical trial (NCT04751435) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced educational materials for genetic testing specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all educational materials for genetic testing clinical trials near you to find additional studies recruiting in your area.

More Neuroendocrine Tumors Trials in New York, NY

See all neuroendocrine tumors clinical trials recruiting in New York — not just this study.

Browse Neuroendocrine Tumors Trials in New York →

Browse More Trials by Condition

Neuroendocrine Tumors TrialsALS TrialsEssential Tremor TrialsUlcerative Colitis TrialsErectile Dysfunction TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY